Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cryo-EM structure of the IL-10 receptor complex provides a blueprint for ligand engineering. | FEBS J | 2022 | 34543517 | PubTator, text mining | PubMed |
| Tofacitinib Suppresses IL-10/IL-10R Signaling and Modulates Host Defense Responses in Human Macrophages. | J Invest Dermatol | 2022 | 34536483 | PubTator, text mining | PubMed |
| Failure to thrive: A severe manifestation of interleukin 10 receptor A mutation in adult inflammatory bowel disease. | JPEN J Parenter Enteral Nutr | 2022 | 34423458 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Livers of Inactive Carriers of Hepatitis B Virus With Distinct Expression of Hepatitis B Surface Antigen. | J Infect Dis | 2022 | 34279652 | PubTator, text mining | PubMed |
| Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease. | Alzheimers Dement | 2022 | 34223696 | PubTator, text mining | PubMed |
| Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies. | J Cancer Res Clin Oncol | 2022 | 34152493 | PubTator, text mining | PubMed |
| A Systematic Review of Monogenic Inflammatory Bowel Disease. | Clin Gastroenterol Hepatol | 2022 | 33746097 | PubTator, text mining | PubMed |
| Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis. | Eur Heart J Open | 2021 | 35919269 | PubTator, text mining | PubMed |
| Implications of Inflammatory States on Dysfunctional Immune Responses in Aging and Obesity. | Front Aging | 2021 | 35822048 | PubTator, text mining | PubMed |
| Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach. | Front Toxicol | 2021 | 35295115 | PubTator, text mining | PubMed |
| Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering. | Front Oncol | 2021 | 35155192 | PubTator, text mining | PubMed |
| An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases. | Front Pharmacol | 2021 | 35153741 | PubTator, text mining | PubMed |
| A Preliminary Inquiry Into the Potential Mechanism of Huang-Lian-Jie-Du Decoction in Treating Rheumatoid Arthritis via Network Pharmacology and Molecular Docking. | Front Cell Dev Biol | 2021 | 35127697 | PubTator, text mining | PubMed |
| Short Chain Fatty Acids Taken at Time of Thrombectomy in Acute Ischemic Stroke Patients Are Independent of Stroke Severity But Associated With Inflammatory Markers and Worse Symptoms at Discharge. | Front Immunol | 2021 | 35126360 | PubTator, text mining | PubMed |
| Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma. | Transl Cancer Res | 2021 | 35116502 | PubTator, text mining | PubMed |
| Primary Immunodeficiencies Associated With Early-Onset Inflammatory Bowel Disease in Southeast and East Asia. | Front Immunol | 2021 | 35095863 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease. | Front Neurol | 2021 | 35095746 | PubTator, text mining | PubMed |
| Liver Fibrosis-From Mechanisms of Injury to Modulation of Disease. | Front Med (Lausanne) | 2021 | 35087852 | PubTator, text mining | PubMed |
| Single-Cell Profiles of Age-Related Osteoarthritis Uncover Underlying Heterogeneity Associated With Disease Progression. | Front Mol Biosci | 2021 | 35083277 | PubTator, text mining | PubMed |
| ILeukin10Pred: A Computational Approach for Predicting IL-10-Inducing Immunosuppressive Peptides Using Combinations of Amino Acid Global Features. | Biology (Basel) | 2021 | 35053004 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=46